0
     

Report Added
Report already added
Rx/Reimbursement Adult Incontinence in Latvia

Rx/Reimbursement Adult Incontinence in Latvia

Rx/reimbursement adult incontinence was largely unaffected by the pandemic, as it is an essential product. In 2021, volume growth was on par with 2020, though value growth was higher, due to price rises. Moderate/heavy adult incontinence products performed better than light, as consumers who are diagnosed with incontinence issues by a doctor, usually have quite serious incontinence issues.

Euromonitor International's Rx/Reimbursement adult incontinence in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2026 illustrate how the market is set to change.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Rx/Reimbursement Adult Incontinence in Latvia

List Of Contents And Tables

RX/REIMBURSEMENT ADULT INCONTINENCE IN LATVIA
KEY DATA FINDINGS
2021 DEVELOPMENTS
Rx/reimbursement adult incontinence unaffected by pandemic
Erosion of taboos and increasing consumer awareness benefit the product area
Delays in being approved deters some users
PROSPECTS AND OPPORTUNITIES
Healthy constant value growth over forecast period
Inflation could encourage more users to apply for reimbursement
Increasing pressure on public finances
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2016-2021
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2016-2021
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2021-2026
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2021-2026
TISSUE AND HYGIENE IN LATVIA
EXECUTIVE SUMMARY
Tissue and hygiene in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2016-2021
Table 6 Infant Population 2016-2021
Table 7 Female Population by Age 2016-2021
Table 8 Total Population by Age 2016-2021
Table 9 Households 2016-2021
Table 10 Forecast Infant Population 2021-2026
Table 11 Forecast Female Population by Age 2021-2026
Table 12 Forecast Total Population by Age 2021-2026
Table 13 Forecast Households 2021-2026
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2016-2021
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2016-2021
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2017-2021
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2018-2021
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2016-2021
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2016-2021
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2021
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2021-2026
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2021-2026
DISCLAIMER
SOURCES
Summary 1 Research Sources

Report Title: Rx/Reimbursement Adult Incontinence in Latvia


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW